North American COVID-19 ST-Segment-Elevation Myocardial Infarction (NACMI) Registry: Rationale, Design, and Implications | SCAI
Jul 2nd 2021

North American COVID-19 ST-Segment-Elevation Myocardial Infarction (NACMI) Registry: Rationale, Design, and Implications

The multicenter NACMI registry will collect data regarding ST elevation on ECG in COVID-19 patients to determine the etiology and associated clinical outcomes. The collaboration and speed with which this registry has been created, refined, and promoted serves as a template for future research endeavors.

All Authors: Payam Dehghani, MD, FSCAI; Laura J. Davidson, MD, MS, FSCAI; Cindy L. Grines, MD, MSCAI; Keshav Nayak, MD, FSCAI; Jacqueline Saw, MD, FSCAI; Prashant Kaul, MD, FSCAI; Bagai Akshay MD, MHS; Ross Garberich, MS, MBS; Christian Schmidt, MS; Hung Q. Ly, MD, SM; Jay Giri, MD, MPH, FSCAI; Perwaiz Meraj, MD, FSCAI; Binita Shah, MD, FSCAI; Santiago Garcia, MD, FSCAI; Scott Sharkey, MD; David A. Wood, MD, FSCAI; Frederick G. Welt, MD, MSc, FSCAI; Ehtisham Mahmud, MD, MSCAI; Timothy D. Henry, MD, MSCAI.